Wordt geladen...
Monitoring Ponatinib in a Child with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Ponatinib is a third-generation tyrosine kinase inhibitor (TKI) reported to show a higher efficacy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) than other TKIs. However, few studies describe ponatinib for pediatric Ph+ALL; therefore, the efficacy, safety, and opti...
Bewaard in:
| Gepubliceerd in: | Case Rep Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
S. Karger AG
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7983555/ https://ncbi.nlm.nih.gov/pubmed/33776678 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000511071 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|